According to Nielsen® syndicated data for the latest 52 weeks' period ending February 22, 2025, the MiraLAX® Powder for Solution, 17 grams (OTC) market 3 achieved annual sales of approximately $555.7 ...
Ani Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for Polyethylene Glycol 3350 Powder for Oral Solution. Ani ...
https://www.thehindubusinessline.com/markets/stock-markets/glenmark-launches-over-the-counter-laxative-to-compete-with-miralax/article69312141.ece Copy Glenmark ...
Polyethylene glycol (PEG) 3350; pwd for reconstitution. Polyethylene glycol 3350 cleanses the bowel by induction of diarrhea. The osmotic activity of polyethylene glycol 3350, in combination with the ...
The Asia-Pacific polyethylene glycol market is being driven by the pharmaceutical industry is a key driver driving market expansion. Polyethylene glycols are crucial components of pharmaceutical ...
Glenmark Therapeutics Inc., USA (Glenmark) announced the launch of polyethylene glycol 3350, powder for solution, 17 grams/capful (OTC); compare to the active ingredient in MiraLAX powder for solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results